Xue Han

Xue Han is a biostatistician currently serving as the Associate Director of Biostatistics at Kyverna Therapeutics, where they focus on autoimmune and CAR-T therapies studies. In addition to this role, Xue works as a freelance consultant at Primus. Previously, Xue held positions as a Principal Biostatistician at Atara Biotherapeutics and Clinical Trial Biostatistician at Fred Hutch, contributing to research on HIV and COVID vaccine clinical trials. They earned a Master of Public Health in Biostatistics from the University of Maryland, where they also obtained a Master’s degree in Molecular Virology.